Virtus Investment Advisers’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Buy
6,126
+147
+2% +$7.98K 0.1% 258
2025
Q4
$276K Buy
5,979
+2,677
+81% +$120K 0.08% 278
2025
Q3
$119K Buy
3,302
+573
+21% +$19K 0.03% 406
2025
Q2
$88.7K Buy
2,729
+857
+46% +$28.1K 0.03% 387
2025
Q1
$70.7K Buy
+1,872
New +$150K 0.02% 453
2024
Q2
Sell
-3,178
Closed -$217K 367
2024
Q1
$217K Hold
3,178
0.16% 183
2023
Q4
$200K Hold
3,178
0.15% 191
2023
Q3
$162K Hold
3,178
0.11% 193
2023
Q2
$159K Hold
3,178
0.11% 208
2023
Q1
$119K Sell
3,178
-109
-3% -$4.62K 0.08% 237
2022
Q4
$158K Buy
+3,287
New +$129K 0.11% 220

Other funds holding PCVX